All posts by : Felistas

In a groundbreaking medical achievement in the U.K., a 32-year-old woman from Manchester has undergone the country’s first liver transplant for advanced bowel cancer.

Patients are having difficulty finding or keeping a primary care provider. They’re experiencing long waits to see a doctor, relying more on emergency rooms and urgent care clinics when sick, and having trouble scheduling yearly well visits, which are crucial for managing chronic illnesses and delivering preventive care.

As we begin the new year, many people might be thinking about improving their diet and overall health. As an oncology dietitian at UK Markey Cancer Center, I’m often asked about the connection between diet and cancer prevention. While there’s a lot of conflicting nutrition information online, the evidence-based answer is that a diet rich in plant-based foods can help reduce your cancer risk.

Low-density lipoproteins (LDL)—commonly known as bad cholesterol—have long been on scientists’ radar as a major contributor to heart disease. But these microscopic troublemakers have hidden their inner workings behind a maze of complexity. That is, until now.

The mere mention of Leonardo da Vinci evokes genius. We know him as a polymath whose interests spanned astronomy, geology, hydrology, engineering and physics. As a painter, his Mona Lisa and Last Supper are considered works of mastery.

Patients taking a commonly used stimulant for the treatment of binge eating disorder experienced mixed results, according to Rutgers Health researchers.

A national study seeking more effective treatment for deadly metaplastic breast cancer has identified two inhibitor drugs with the potential to interrupt disease progression.

Rutgers Health researchers have discovered that brain immune cells from people with a high genetic risk for alcohol use disorder (AUD) behave differently than cells from low-risk people when exposed to alcohol.

The incidence of advanced prostate cancer in California rose markedly in the decade since doctors stopped routinely screening all men for the disease, according to a new study by UC San Francisco.

A research group from the Institute for Research on Next-generation Semiconductor and Sensing Science (IRES²) at Toyohashi University of Technology has developed an innovative in vivo electrophysiological neural recording technology that minimizes neuronal death and allows stable recordings for over a year.